VISCERA

What VISCERA does

VISCERA AG is a Swiss medical practice group specializing in abdominal medicine (Bauchmedizin), integrating visceral surgery with gastroenterology and hepatology under a single patient pathway. Founded in 2021 and headquartered in Bern at Waaghaus-Passage 8, the group operates practice locations in Bern, Luzern, and Thun, with new sites planned in Zürich-Feldmeilen and Murten for April 2026. Its core services span outpatient consultations in gastroenterology and hepatology, surgical procedures (hernia repair, gallbladder removal, liver, pancreas, colorectal, and bariatric surgery), and complex oncological procedures including HIPEC and HSM-certified resections. Differentiation rests on the integration of diagnostics, minimally invasive and robotic surgery (da Vinci and Dexter systems), and specialized regulatory authorizations for five HSM surgical categories.

The practice operates within the Swiss mandatory health insurance framework, billing outpatient services under TARMED and inpatient procedures under SwissDRG at partner hospitals. Patient acquisition is primarily referral-driven through general practitioners and specialists (Zuweiser), supplemented by second-opinion services and public education events. Surgical cases are performed at accredited partner hospitals — primarily Lindenhofgruppe (Lindenhofspital, Spital Engeried) and Hirslanden (Klinik Beau-Site, Salemspital, Opera ambulatory center, Clinique Cécile Lausanne) — while outpatient consultations and diagnostics occur at VISCERA's own practice locations. The group also operates a wound care clinic (Wundsprechstunde), offers novel techniques such as eTEP robotic hernia repair, PTNS for incontinence, and fish skin wound treatment, and publishes peer-reviewed research in leading surgical journals.

VISCERA is a privately-held Swiss Aktiengesellschaft (AG), physician-owned and operated by a partnership of senior surgeons and gastroenterologists including multiple professors and PD-level physicians. The group has grown from 7 physicians at inception to approximately 10 employees by 2026, with 60+ robotic-assisted procedures completed as of June 2025. Multi-site expansion across German-speaking Switzerland, continuous introduction of new surgical techniques, and a partnership-based ecosystem with hospitals, referring physicians, and research institutions (Clarunis, St. Clara Forschung) form the strategic backbone of the practice.

Name

VISCERA

Legal name

VISCERA AG

Website

https://viscera.ch

Company type

Private

Founded year

2022

Operating status

Operating

Short description

VISCERA AG is a Swiss medical practice group in Bern specializing in abdominal medicine, integrating visceral surgery with gastroenterology and hepatology across multiple locations in German-speaking Switzerland. It serves patients with abdominal conditions through referrals, performing advanced robotic and minimally invasive procedures at partner hospitals.

Ownership category

akta.pro rank

Headquarters

HQ city

Bern

HQ country

Switzerland

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Consultation Services: Outpatient consultations in gastroenterology, hepatology, and visceral surgery. Revenue generated through Swiss health insurance system (TARMED billing).
2. Surgical Procedures: Both inpatient and outpatient surgical procedures performed at partner hospitals (Lindenhof, Hirslanden). Revenue through Swiss diagnosis-related groups (DRG) billing at hospitals, with practice physician fees.
3. Diagnostic Services: Endoscopic procedures, functional diagnostics, imaging, and laboratory coordination. Billed through Swiss health insurance framework.
4. Wound Care and Specialized Treatments: Wound clinic services including vacuum therapy and specialized wound treatments, recognized by health insurance providers.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Core offering

VISCERA is a Swiss specialist medical practice group (VISCERA AG) providing integrated visceral surgery and gastroenterology/hepatology care, from diagnosis through complex surgical treatment to follow-up. The practice operates multiple outpatient sites in German-speaking Switzerland (Bern, Luzern, Thun, with planned expansion to Zürich and Murten), performs inpatient surgery at partner hospitals, and is government-authorized for highly specialized medicine (HSM) procedures including complex hernia repair and HIPEC.

Product overview

VISCERA is a Swiss medical group practice specializing in abdominal medicine (Bauchmedizin) with multiple locations (Bern, Luzern, Thun, Zürich). The practice operates as an integrated platform combining visceral surgery and gastroenterology/hepatology services. Core offerings include surgical procedures (open, laparoscopic, and robot-assisted using da Vinci and Dexter systems), medical gastroenterology and hepatology treatments, specialized HSM (Highly Specialized Medicine) procedures, and diagnostic services. The practice provides comprehensive patient pathways from consultation through surgery and post-operative care, with locations in Bern (Waaghaus-Passage 8), Luzern (Hertensteinstrasse 50), Thun (Bälliz 44), and Zürich (General-Wille-Strasse 65). Key services include second opinions, wound care clinic, and advanced techniques such as transanal endoscopic microsurgery (TEM), PTNS for incontinence, breath tests, and complex oncological surgeries including HIPEC.

Differentiator

Problem solved

Functional benefit

Products and services

• Visceral Surgery Outpatient consultation and inpatient surgical treatment for abdominal and digestive-tract conditions including hernia repair (open, laparoscopic, eTEP robotic), HPB (hepato-pancreato-biliary) surgery, gallbladder and colorectal surgery, TEM, and HIPEC for peritoneal disease. Patients are seen at the practice clinic and operated on at partner hospitals (Lindenhofgruppe, OPERA, Clarunis).
• Gastroenterology and Hepatology Diagnostic and therapeutic gastroenterology and hepatology consultations, including gastroscopy/colonoscopy, capsule endoscopy, functional diagnostics, breath tests, FODMAP/intestinal pseudo-obstruction evaluation, and liver disease workup using LiMAx liver function testing. Targeted at patients with abdominal complaints, liver disease, and digestive disorders.
• Second Opinion Service

Quantifiable outcome

• 80% success rate improvement in incontinence symptoms with PTNS treatment
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• Praxis Seeblick, FeldmeilerminorChannel Partner/ Reseller/ Distributor · 21 March 2026VISCERA Bauchmedizin Zürich opening at Praxis Seeblick in Feldmeilen with Prof. Erik Schadde offering general and visceral surgery consultations. Open House event scheduled March 21, 2026.
• Gastroenterologie ThunminorStrategic or Co-development Partner · 15 November 2024Partnership to offer comprehensive, state-of-the-art gastroenterological functional diagnostics. Combines VISCERA's surgical capabilities with gastroenterology expertise for effective GI complaint investigations.
• Chirurgiezentrum ThunminorStrategic or Co-development Partner · 3 January 2024Collaboration with Dr. René Stouthandel and new surgeon Dr. Mareike Oulevey Meier for regional surgical care. Ambulatory and general surgical procedures performed at Chirurgiezentrum Thun and Klinik Homad. Complex visceral procedures can be planned at VISCERA Bern's partner hospitals (Beau-Site, Lindenhof) within the collaboration.
• St. Clara Forschung (Clarunis Universitäres Bauchzentrum Basel)minorStrategic or Co-development Partner · 11 October 2023PD Dr. Mathias Worni participates in research projects including a multicenter prospective study on left-sided colorectal resection. Clarunis is a network including Lindenhofspital Bern. Founded for surgical training and continuing education, now also focused on clinical research.
• Dr. Roman Bühlmann (Vascular Surgery)minorImplementation/ SI/ Consulting Partner · 16 April 2023Dr. Bühlmann uses VISCERA's practice infrastructure for his vascular surgery consultations, optimizing facility utilization. Adds aortic and vascular surgery services to the practice's offerings.
• Onkologie/Hämatologie Praxis Solothurn (Dr. von Burg, Prof. Bonadis)minorStrategic or Co-development Partner · 26 March 2023Multidisciplinary partnership for hematology and oncology care. Joint treatment recommendations formulated through interdisciplinary team discussions to find optimal patient solutions. Extends VISCERA's cancer care capabilities.
• Lindenhofgruppe (Lindenhofspital, Spital Engeried)coreStrategic or Co-development PartnerLong-standing partnership with Bern's leading private hospital group. VISCERA surgeons accredited and perform surgeries at both Lindenhofspital and Spital Engeried. Enables inpatient surgical procedures with modern infrastructure and quality nursing care. Partnership supports the practice's 24/7 emergency availability commitment.
• Hirslandengroup (Klinik Beau-Site, Salem-Spital, Bern; Clinique Cécile, Lausanne)coreStrategic or Co-development PartnerMost VISCERA surgeons are accredited at Hirslanden Bern locations (Beau-Site, Salem-Spital). Prof. Müller also performs procedures at Clinique Cécile in Lausanne for HPB cases. Hirslanden Opera clinic used for ambulatory robotic surgeries. Supports HSM-complex procedures and provides access to private hospital infrastructure.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Clarunis Universitäres Bauchzentrum Basel: University-affiliated Swiss specialty center for abdominal medicine combining visceral surgery and gastroenterology/hepatology. Directly comparable to VISCERA in service mix and Swiss HSM-eligible case profile; explicitly named as a VISCERA research collaboration partner on colorectal resection studies.

Broad incumbents

• Lindenhofgruppe: Leading Bern private hospital group operating Lindenhofspital and Spital Engeried. VISCERA's core inpatient surgical partner; comparable as a broader multi-specialty private hospital operator with overlapping surgical and gastroenterology service lines, but operating at hospital rather than ambulatory specialist scale.
• Hirslanden: Switzerland's largest private clinic group (17 clinics including Klinik Beau-Site, Salemspital, Clinique Cécile Lausanne, and the OPERA ambulatory center). Comparable as incumbent private healthcare operator where VISCERA holds surgical privileges; broader portfolio includes cardiology, orthopedics, and oncology beyond abdominal medicine.
• Inselspital Bern (University Hospital Bern): Swiss university hospital providing full tertiary care including visceral surgery, gastroenterology, and HSM-eligible procedures. Comparable as the public-sector incumbent in Bern with overlapping specialty referral base, though operating at significantly larger academic-hospital scale.

Regional players

• Schoen Klinik: Germany's largest family-owned specialty hospital group with focus areas including abdominal and visceral surgery. Comparable as a multi-site, specialty-led private hospital operator with similar center-of-excellence positioning, though operating primarily in the German inpatient market.
• Asklepios Kliniken: One of Germany's largest private hospital operators with broad specialty coverage including abdominal surgery and gastroenterology. Comparable as a multi-site specialty healthcare platform, though with a primarily German public-pay reimbursement model and significantly larger scale.
• Helios (Fresenius): European hospital group (part of Fresenius) operating ~90 hospitals across Germany, Spain, and Latin America with extensive visceral surgery and gastroenterology coverage. Comparable as a large private multi-site hospital operator with overlapping specialty footprint in the DACH region.
• Spire Healthcare: UK-listed private hospital group operating ~38 hospitals across the UK with specialist surgical services including general and abdominal surgery. Comparable as a private-pay-focused specialty hospital operator, though serving the UK rather than Swiss market.
• Mediclinic International: International private hospital group with operations in Switzerland (Hirslanden predecessor footprint), Southern Africa, and the UAE. Comparable as a multi-geography private hospital operator, though at materially larger scale and broader specialty portfolio than VISCERA.
• HCA Healthcare: Largest US for-profit hospital operator (~190 hospitals) with strong presence in specialty surgical services. Comparable as a large private healthcare platform with sophisticated physician-alignment models, though operating primarily in the US inpatient market at vastly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VISCERA